Skip to main content
. Author manuscript; available in PMC: 2013 Aug 15.
Published in final edited form as: Leukemia. 2010 Jun 24;24(9):1555–1565. doi: 10.1038/leu.2010.142

Figure 4. Enhanced anti-proliferative effects of HXR9 and ch128.1Av in U266 and KMS-11 cells.

Figure 4

Cells were treated in triplicates with the indicated concentrations of HXR9, ch128.1Av, or the various combinations of the two compounds for 96 hours. Cytotoxicity was determined by the [3H]-thymidine incorporation assay. Results are representative of two independent experiments. * p-value < 0.05 when compared to both agents alone used at the same concentrations.